Published in Hepatitis Weekly, July 26th, 1999
In this study, C.J. Ingardia and colleagues of Connecticut's Hartford Hospital examined seroprotective antibody response after hepatitis B vaccination during pregnancy. They also assessed factors influencing the rate of maternal seroprotection ("Hepatitis B Vaccination in Pregnancy: Factors Influencing Efficacy," Obstetrics and Gynecology, June 1999;93(6):983(6):983-986).
Records of 80 healthy gravidas who elected hepatitis B vaccination during pregnancy, after being identified as hepatitis B surface antigen (HBsAg) and antibody...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1999-07-26)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.